SpringerLink
Log in

Disorders of Neurotransmission

  • Chapter
Physician’s Guide to the Treatment and Follow-Up of Metabolic Diseases

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 229.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Baxter P (2001) Pyridoxine dependent and pyridoxine responsive seizures. In: Baxter P (ed) Vitamin responsive conditions in paediatric neurology.MacKeith, London, pp 166–175

    Google Scholar 

  2. Becker C-M (1995) Glycine receptors: molecular heterogeneity and implications for disease. Neuroscientist 1:130–141

    CAS  Google Scholar 

  3. Biaggioni I, Robertson D (1987) Endogenous restoration of noradrenaline by precursor therapy in dopamine-beta-hydroxylase deficiency. Lancet 2:1170–1172

    CAS  PubMed  Google Scholar 

  4. Biaggioni I, Goldstein DS, Atkinson T, Robertson D (1990) Dopamine β-hydroxylase deficiency in humans. Neurology 40:370–373

    CAS  PubMed  Google Scholar 

  5. Birnbacher R, Scheibenreiter S, Blau N, Bieglmayer C, Frisch H, Waldhauser F (1998) Hyperprolactinemia, a tool in treatment control of tetrahydrobiopterin deficiency: endocrine studies in an affected girl. Ped Res 43:472–477

    CAS  Google Scholar 

  6. Brunner HG, Nelen MR, Zandvoort P van, Abeling NGGM, Gennip AH van, Wolters EC, Kuiper MA, Ropers HH, Oost BA van (1993) X-linked borderline mental retardation with prominent behavioral disturbance: phenotype, genetic localisation, and evidence for disturbed monoamine metabolism. Am J Hum Genet 52:1–8

    Google Scholar 

  7. Cheung NW, Earl J (2002) Monoamine oxidase deficiency. A cause of symptomatic hyperserotoninemia in the absence of carcinoid. Arch Inter Med 162:1647–1648

    Google Scholar 

  8. Clayton PT, Surtees RAH, DeVile C, Hyland K, Heales SJR (2003) Neonatal epileptic encephalopathy. Lancet 361:1614

    Article  CAS  PubMed  Google Scholar 

  9. Hoffmann GF, Surtees RAH, Wevers RA (1998) Cerebrospinal fluid investigations for neurometabolic disorders. Neuropediatrics 29:59–71

    CAS  PubMed  Google Scholar 

  10. Hoffmann GF, Assmann B, Bräutigam C, Dionisis-Vici C, Häussler M, Klerk J de, Naumann M, Steenbergen-Spanjers G, Strassburg HM, Wevers RA (2003) Tyrosine hydroxylase deficiency causes progressive encephalopathy and dopa-nonresponsive dystonia. Ann Neurol (Suppl. 6) 54:56–65

    Google Scholar 

  11. Hyland K, Buist NRM, Powell BR, Hoffmann GF, Rating D, McGrath J, Acworth IN (1995) Folinic acid responsive seizures: a new syndrome? J Inher Metab Dis 18:177–181

    Article  CAS  PubMed  Google Scholar 

  12. Surtees R, Clayton P (1998) Infantile parkinsonism-dystonia: tyrosine hydroxylase deficiency. Movement Disord 13:350

    Article  Google Scholar 

  13. Surtees R, Hyland K (1990) L-3,4-Dihydroxyphenylalanine (levodopa) lowers central nervous system S-adenosylmethionine concentrations in humans. J Neurol Neurosurg Psychiatr 53:569–572

    CAS  PubMed  Google Scholar 

  14. Swoboda KJ, Saul JP, McKenna CE, Speller NB, Hyland K (2003) Aromatic l-amino acid decarboxylase deficiency. Overview of clinical features and outcomes. Ann Neurol (Suppl. 6) 54:49–55

    Google Scholar 

  15. Tijssen MA, Schoemaker HC, Edelbroek PJ, Roos RA, Cohen AF, Dijk JG van (1997) The effects of clonazepam and vigabatrin in hyperekplexia. J Neurol Sci 149:63–67

    Article  CAS  PubMed  Google Scholar 

Download references

Authors
  1. Georg F. Hoffmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert Surtees
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Clinical Chemistry and Biochemistry, University Children’s Hospital, Steinwiesstrasse 75, 8032, Zurich, Switzerland

    Nenad Blau

  2. Biochemistry, Endocrinology and Metabolism Unit, Institute of Child Health, 30, Guilford Street, London, WC1N 1EH, UK

    James Leonard

  3. Universitätsklinik für Kinder- und Jugendmedizin, Im Neuenheimer Feld 150, D-69120, Heidelberg, Germany

    Georg F. Hoffmann

  4. Division of Clinical & Metabolic Genetics, Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, M5G 1X8, Canada

    Joe T. R. Clarke

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Hoffmann, G.F., Surtees, R. (2006). Disorders of Neurotransmission. In: Blau, N., Leonard, J., Hoffmann, G.F., Clarke, J.T.R. (eds) Physician’s Guide to the Treatment and Follow-Up of Metabolic Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-28962-3_4

Download citation

  • DOI: https://doi.org/10.1007/3-540-28962-3_4

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-22954-4

  • Online ISBN: 978-3-540-28962-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation